期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

弥漫性大B细胞淋巴瘤的分型与预后的研究进展 被引量：2

暂未订购
导出
摘要 弥漫性大B细胞淋巴瘤（diffuse large B cell lymphoma，DLBCL）是一组在形态学、遗传学和临床表现上都具有异质性的肿瘤，是非霍奇金淋巴瘤中最常见的类型，在西方国家约占30％～40％，而在发展中国家比例还要高些。这类肿瘤发生于淋巴结内或结外任何部位．可为原发或由其它低度恶性淋巴瘤转化而来。化学治疗通常能改善DLBCL患者的生存预后．但是由于遗传异质性而导致DLBCL患者的临床特征及对治疗反应的不同．约有50％的患者不能通过标准的治疗方案治愈．
作者 刘勇 杨海玉 路名芝
机构地区 江西省人民医院病理科
出处 《江西医学检验》 2007年第1期48-50,56,共4页 Jiangxi Journal of Medical Laboratory Sciences
关键词 大B细胞淋巴瘤 弥漫性 预后 LYMPHOMA 非霍奇金淋巴瘤 DLBCL 遗传异质性 分型
分类号 R733 [医药卫生—肿瘤]
  • 相关文献

参考文献28

  • 1Pileri SA,Dirnhofer S,Ascani S,et al.Diffuse large B-cell lymphoma:one or more entities? Present controversies and possible tools for its subclassification[J].Histopathology,2002,41:482～509.
  • 2Jaffe ES,Harris NL,Stein H,et al.WHO Classification of tumors[M].Pathology and genetics of tumors of haematopoietic and lymphoid tissues.Lydon,France:International Agency for Research on Cancer(IARC) Press,2001,171～174.
  • 3Colomo L,Lopez-Guillermo A,Perales M,et al.Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma[J].Blood,2003,101:78～84.
  • 4Alzadeh AA,Eisen MB,Davis RE,et al.Distinct types of diffuse large B-cell lymphoma identifiec by gene expression profiling[J].Nature,2000,403:503～511.
  • 5Rosenwald A,Wright G,Chan WC,et al.The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma[J].N Engl J Med,2002,346:1937-1947.
  • 6Lossos IZ,Czerwinski DK,Alianeh AA,et al.Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes[J].N Engl J Med,2004,350:1828～1837.
  • 7Zhang A,Ohshima K,Sato K,et al.Prognostic clinicopathologic factors,including immunologic expression in diffuse large B-cell lym-phomas[J].Pathol Int,1999,49:1043～1052.
  • 8Huang JZ,Sanger WG,Greiner TC,et al.The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell geng expression prifile[J].Blood,2002,99:2285～2290.
  • 9Kramer MH,Hermans J,Wijburg E,et al.Clinical relevance of BCL2,BCL6,and MYC rearrangements in diffuse large B-cell lymphoma[J].Blood,1998,92:3152～3162.
  • 10Monni O,Joensuu H,Franssila K,et al.BCL2 overexpression associated with chromosomal amplification in diffuse lare B-cell lymphoma[J].Blood,1997,90:1168～1174.

二级参考文献10

  • 1Armitage JO, Weisenburger DD. New approach to classifying non-hodgikin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgikin′s Lympohma Classification Project[J].J Clin Ocol, 1998, 16(8): 2780～2795
  • 2Adida C, Crotty PL, McGrathJ, et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation [J]. AmJ Pathol, 1998, 152(1):43 -49
  • 3Yoshida H, Ishiko O, Sumi T, et al. Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell-and serous-type ovarian carcinomas[J]. IntJ Oncol, 2001, 19(3):537-542
  • 4Adida C, Haioun C, Gaulard P, et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas [J]. Blood,2000, 96(5): 1921-1925
  • 5Monz6 M, Rosell R, Felip E, et al. A novel anti-apoptosis gene:re-expression of surviving messenger RNA as a prognosis marker in non-small-cell lung cancers [J]. J Clin Oncol, 1999, 17 (7):2100 -2104
  • 6Okada E, Murai Y, Matsui K, et al. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patient[J]. Cancer Letters, 2001, 163(1): 109-116
  • 7Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by surviving [J]. Nature, 1998, 396(6711):580-584
  • 8Kawasaki H, Toyoda M, Shinahara H, et al. Expression of surviving correslates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis [J]. Cancer, 2001, 91 (11):2026-2032
  • 9Satoh K, Kaneko K, Hirota M, et al. Expression of surviving is correlated with cancer cell apoprtosis and is involved in the development of human pancreatic duct cell tumors[]]. Cancer, 2001,92(2): 271-278
  • 10The International Non-Hodgikin′s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-hodgikin's lymphoma[J]. N EnglJ Med, 1993, 329(14): 987-994

共引文献12

同被引文献19

  • 1王焱,周晓军.弥漫性大B细胞淋巴瘤[J].医学研究生学报,2006,19(3):277-280. 被引量：9
  • 2Harris NL,Jaffe ES,Stein H,et al.A revised European-American classification of lymphoid neoplasms:a proposal from the international lymphoma study group.Blood 1994;84(5):1361-l392.
  • 3Pandolfino TL,Siegel RS,Kuzel TM,et al.Primary cutaneous B-cell lymphoma:review and current concepts.J Clin Oncol 2000;18(10):2152-2168.
  • 4Leboit PE,Berg G,Weedon D,et al.廖松林,主译.皮肤肿瘤病理学和遗传学.第1版.北京:人民卫生出版社,2006.229.
  • 5Yamaguchi M,Seto M,Okamoto M,et al.Denovo CD5+ diffuse large B-cell lymphoma:a clinicopathologic study of 109 patients.Blood 2002;99(3):815-821.
  • 6Hans CP,Weisenburger DD,Greiner TC,et al.Confirmation of the mo-lecular classification of diffuse large B-cell lymphoma by immunohisto-chemistry using a tissue microarray.Blood 2004;10(3):275-282.
  • 7Barrans SL,Carter I,Owen RG,et al.Germinal center phenotype and bcl-2 expression combined with the international prognostic index improves patient risk stratification in diffuse large B-cell lmphoma.Blood 2002;99(4):1136-1143.
  • 8许霞,庞宗国,刘卫平,张尚福,唐源,廖殿英,李甘地.血管内大B细胞淋巴瘤尸体解剖临床病理分析[J].中华病理学杂志,2008,37(6):377-383. 被引量：18
  • 9王佳,包叶江.以腹水为首发表现的Burkitt淋巴瘤一例[J].实验与检验医学,2011,29(2):205-206. 被引量：3
  • 10管冰心,潘毅,房爱菊,梁艳,霍颖颖,孙保存,王华庆,付凯,孟斌.219例弥漫性大B细胞淋巴瘤免疫表型及遗传学特征分析[J].中国肿瘤临床,2012,29(12):829-833. 被引量：9

引证文献2

二级引证文献3

江西医学检验
2007年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部